The angiogenic switch in hamster buccal pouch keratinocytes is dependent on TGFβ-1 and is unaffected by ras activation

Carcinogenesis

Volumn 18, Issue 2, 1997, Pages 329-338

  Lingen, Mark W ^a   Dipietro, Luisa A ^a,c   Solt, Dennis B ^a   Bouck, Noël P ^a   Polverini, Peter J ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANCHORAGE INDEPENDENT GROWTH; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CHEEK POUCH; CONTROLLED STUDY; DNA TRANSFECTION; GENE ACTIVATION; HAMSTER; KERATINOCYTE; MALE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CELLS, CULTURED; CHEEK; CRICETINAE; GENE EXPRESSION REGULATION; GENES, RAS; KERATINOCYTES; MALE; MESOCRICETUS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031408923     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.2.329     Document Type: Article

References (55)

1. Vokes, E.E., Weichselbaum, R.R., Lippman, S.M. and Hong, W.K. (1993) Head and neck cancer. N. Engl. J. Med., 328, 184-194.
2. Field, J.K. (1992) Oncogenes and tumor-suppressor genes in squamous cell carcinoma of the head and neck. Oral Oncol. Eur. J. Cancer, 28B, 67-76.
3. Boring, C.C., Squire, T.S., Tong, T. and Montgomery, S. (1994) Cancer statistics. Calif. Cancer J. Clin., 44, 7-26.
4. Moroco, J.R., Solt, D.B. and Polverini, P.J. (1990) Sequential loss of suppressor genes for three specific functions during in vivo carcinogenesis. Lab Invest., 63, 298-306.
5. Husain, Z., Fein, Y., Roy, S., Solt, D.B., Polverini, P.J. and Biswas, D.K. (1989) Sequential expression and cooperative interaction of c-Ha-ras and c-erb B genes in in vivo carcinogenesis. Proc. Natl Acad. Sci. USA, 86, 1264-1268.
6. Polverini, P.J. and Solt, D.B. (1988) Expression of the angiogenic phenotype by a subpopulation of keratinocytes derived from 7,12-dimethylbenz[a]anthracene-initiated hamster buccal pouch epithelium. Carcinogenesis, 9, 285-291.
7. Polverini, P.J. and Solt, D.B. (1986) Effect of in vivo carcinogen exposure on colony formation and growth of hamster buccal pouch keratinocytes in culture. Lab. Invest., 54, 432-441.
8. Kwong, Y.Y., Husain, Z. and Biswas, D.K. (1992) c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis. Oncogene, 7, 1481-1489.
9. Chang, K.W., Lin, S.C., Koos, S., Pather, K. and Solt, D.B. (1996) p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas. Carcinogenesis, 17, 595-600.
10. Todd, R., McBride, J., Tsuji, T., Donoff, R.B., Nagal, M., Chou, M.Y., Chiang, T. and Wong, D.T. (1995) Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J, 9, 1362-1370.
11. Folkman J. (1995) Tumor angiogenesis. In Mendelsohn, J., Howley, P.M., Israel, M.A., Liotta, L.A. (eds), The Molecular Basis of Cancer, W.B. Saunders, Philadelphia, pp. 206-232.
12. Bouck, N., Stellmach, V. and Hsu, S. (1995) How tumors become angiogenic. Adv. Cancer Res, in press.
13. Christofori, G. and Hanahan, D. (1994) Molecular dissection of multi-stage tumorigenesis in transgenic mice. Seminars in Cancer Biology, 5, 3-12.
14. Polverini, P.J., Bouck, N.P. and Rastinejad, F. (1991) Assay and purification of naturally occurring inhibitor of angiogenesis. Meth. Enzymol., 198, 440-450.
15. Gimenez-Conti, I.B., Bianchi, A.B., Stockman, S.L., Conti, C.J. and Slaga, T.J. (1992) Activating mutation of the Ha-ras gene in chemically induced tumors of the hamster buccal cheek pouch. Mol. Carcinogenesis, 5, 259-263.
16. Shih, C. and Weinberg, R.A. (1982) Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell, 29, 161-169.
17. Dameron, K.M., Volpert, O.V., Tainsky, M.A. and Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 265, 1582-1584.
18. Dameron, K.M., Volpert, O.V., Tainsky, M.A. and Bouck, N. (1994) The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. Cold Spring Harbor Symp in Quant Biol, LVIX, 1-7.
19. Zenklusen, J.C., Stockman, S.L., Fischer, S.M., Conti, C.J. and Gimenezconti, I.B. (1994) Transforming growth factor-beta-1 expression in Syrian hamster cheek pouch carcinogenesis. Mol Carcinogenesis, 9, 10-16.
20. Roberts, A.B., Sporn, M.B., Assoian, R.K., Smith, J.M., Roche, N.S., Wakefield, L.M., Heine, U.I., Liotta, L.A., Falanga, V. Kehrl, J.H. and Fauci, A.S. (1986) Transforming growth factor type B: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl Acad. Sci., USA, 83, 4167-4171.
21. Yang, E.Y. and Moses, H.L. (1993) Transforming growth factor B1 induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell. Biol., 111, 731-741.
22. Plouet, J. and Gospadarowicz, D. (1989) Transforming growth factor B-1 positively modulates the bioactivity of fibroblast growth factor on corneal endothelial cells. J. Cell. Physiol., 141, 392-399.
23. Myoken, Y., Kan, M., Sato, G.H., Keehan, W.L. and Sato, J.D. (1990) Bifunctional effects of transforming growth factor B (TGF-B) on endothelial cell growth correlates with phenotypes of TGF-B binding sites. Exp. Cell. Res., 191, 299-304.
24. Pepper, M.S., Vassalli, J.D., Orci, L. and Montesano, R. (1993) Biphasic effect of transforming growth factor-B1 on in vitro angiogenesis. Exp. Cell. Res., 204, 356-363.
25. Tolsma, S.S., Volpert, O.V., Good, D.J., Frazier, W.A., Polverini, P.J. and Bouck, N. (1993) Peptides derived from two separate domains of thrombospondin-1 have anti-angiogenic activity. J. Cell. Biol., 122, 497-511.
26. Sporn, M.B. and Roberts, A.B. (1990) The transforming growth factor-βs. In Sporn, M.B. and Roberts, A.B. (eds), Peptide Growth Factors and their Receptors. Springer-Verlag, New York, pp 419-477.
27. Game, S.M., Stone, A., Scully, C. and Prime, S.S. (1990) Tumor progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-B receptor expression and altered responses to these growth factors. Carcinogenesis, 11, 965-973.
28. Missero, C., Cajal, S.R. and Dotto, G.P. (1991) Escape from transforming growth factor B control and oncogene cooperation in skin tumor development. Proc. Natl Acad. Sci. USA, 88, 9613-9617.
29. Reiss, M., Munoz-Antonia, T., Cowan, J.M., Wilkins, P.C., Zhou, Z. and Vellucci, V.F. (1993) Resistance of human squamous cell carcinoma cells to transforming growth factor B1 is a recessive trait. Proc. Natl Acad. Sci. USA, 90, 6280-6284.
30. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S.J., Gesmonde, J., Vellucci, V.F. and Reiss, M. (1995) Missense mutations of the transforming growth factorβ type II receptor in human head and neck squamous cell carcinoma cells. Cancer Res., 55, 3982-3987.
31. Ueki, N., Nakazato, M., Ohkawa, T., Ikeda, T., Amuro, Y., Hada, T. and Higashino, K. (1992) Excessive production of TGFβ can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth. Biochem. Biophysica Acta, 1137, 189-196.
32. Ueki, N., Ohkawa, T., Yokoyama, Y., Maeda, J., Kawai, Y., Ikeda, T., Amuro, Y., Hada, T. and Higashino, K. (1993) Potentiation of metastatic capacity by TGFβ gene transfection. Japan. J. Cancer Res., 84, 589-593.
33. Tada, T., Yabu, K. and Kobayashi, S. (1993) Detection of active form of TGFβ in cerebrospinal fluid of patients with glioma. Japan. J. Cancer Res., 84, 544-548.
34. Walker, R.A. and Dearing, S.J. (1992) TGFβ-1 in ductal carcinoma in situ and invasive carcinoma of the breast. Eur. J. Cancer, 28, 641-644.
35. Dalal, B.I., Kewon, P.A. and Greenberg, A.H. (1993) Immunocytochemical localization of secreted TGFβ-1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am. J. Pathol., 143, 381-389.
36. Gorsch, S.M., Memoli, V.A., Stukel, T.A., Gold, L.I. and Arrick, B. (1992) Immunohistochemical staining for TGFβ-1 associates with disease progression in human breast cancer. Cancer Res., 52, 6949-6952.
37. Steiner, M.S. and Barrack, E.R. (1992) Transforming growth factor β-1 overproduction in human prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol., 6, 15-25.
38. Lingen, M.W., Polverini, P.J. and Bouck, N.P. (1996) Retinoic acid induces cultured cells from human squamous cell carcinomas to become antiangiogenic. Am. J. Pathol., 149, 247-258.
39. Saranath, D., Chang, S.E., Bhoite, L.T., Panchal, R.G., Ker, I.B. and Mehta, A.R., Johnson, N.W. and Deo, M.G. (1991) High frequency mutations in codons 12 and 61 of H-ras oncogene in chewing tobacco related human oral squamous carcinoma in India. Br. J. Cancer, 63, 573-578.
40. Chang, S.E., Bhatia, P., Johnson, N.W., Morgan, P.R., McCormick, F., Young, B. and Hiorns, L. (1991) ras mutations in United Kingdom examples of oral malignancies are infrequent. Inter. J. Cancer, 48, 409-412.
41. Yeudall, W.A., Torrance, L.K., Elsegood, K.A., Speight, E., Scully, C. and Prime, S.S. (1993) ras point mutation is a rare event in premalignant tissue and malignant cells and tissues from oral mucosal lesions. Eur. J. Cancer Oral Oncol., 29B, 63-67.
42. Folkman, J. and Hannahan, D. (1991) Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symposia, 22, 339-347.
43. Marshall, C.J., Vousden, K. and Ozzanne, B. (1985) The involvement of activated ras genes in determining the transformed phenotype. Proc. Royal Soc. Land., 226, 99-106.
44. Glick, A.B., Sporn, M.B. and Yuspa, S.H. (1991) Altered expression of TGF-beta and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras. Mol. Carcinogenesis, 4, 210-219.
45. Kasid, A. and Lippman, M.E. (1987) Estrogen and oncogene mediated growth regulation of human breast cancer cells. J. Steroid Biochem., 27, 1-3.
46. Castelli, C., Sensi, M., Lupetti, R., Mortarini, R., Panceri, P., Anichini, A. and Parmiani, G. (1994) Expression of IL-1α, IL-6 and tumor necrosis factor alpha in human melanoma clones is associated with that of mutated N-ras oncogene. Cancer Res., 54. 4785-4790.
47. Demetri, G.D., Ernst, T.J., Pratt, E.S., Zenzie, B.W., Rheinwald, J.G. and Griffin, J.D. (1990) Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes. J. Clin. Invest., 86, 1261-1269.
48. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T. and Kerbel, R.S. (1995) Mutatn ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55, 4575-4580.
49. Boylin, J.F., Jackson, J., Steiner, M.R., Shih, T.Y., Duigou, G.J., Roszman, T., Fisher, P.B. and Zimmer, S.G. (1990) Role of Ha-ras oncogene in mediating progression of the tumor cell phenotype. Anticancer Res., 10, 717-724.
50. Jankun, J., Maher, V.M. and McCormick, J.J. (1991) Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator. Cancer Res., 51, 1221-1226.
51. Gabrisa, S., Pozzatti, R., Muschel, R.J., Saffiotti, U., Ballin, M., Goldfarb, R.H., Khoury, G. and Liotta, L.A. (1987) Secretion of type IV collagenolytic and metastatic phenotype: induction by transfection w c-Ha-ras but not c-Ha-ras plus Ad2-E1. Cancer Res., 47, 1523-1528.
52. Chen, L.L., Narayanan, R., Hibbs, M.S., Benn, P.A., Clawson, M.L., Lu, G., Rhim, J.S., Greenberg, B. and Mendelsohn, J. (1993) Altered epidermal growth factor signal transduction in activated Ha-ras transformed human keratinocytes. Biochem. Biophys. Res. Commun., 193, 167-174.
53. Glick, A.B., Sporn, M.B. and Yuspa, S.H. (1991) Altered expression of TGF-beta and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras. Mol. Carcinogenesis, 4, 210-219.
54. Kim, S.J., Lee, H.D., Robbins, R.D., Busam, K., Sporn, M.B. and Robert, A.B. (1991) Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc. Natl Acad. Sci., 88, 3052-3056.
55. Dey, B.R., Sukhatme, V.P., Roberts, A.B., Sporn, M.B., Raushcer, F.J. and Kim, S.J. (1994) Repression of the transforming growth factor-beta 1 gene by the Wilm's tumor suppressor gene WT1 gene product. Mol. Endocrinol., 8, 595-602.